edaravone has been researched along with Idiopathic Parkinson Disease in 4 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "The major hallmark of Parkinson's disease (PD) is the degeneration of dopaminergic neurons in the substantia nigra (SN), which is responsible for the core motor symptoms of PD." | 1.72 | The Effects of Novel Formulations of Edaravone and Curcumin in the Mouse Intrastriatal Lipopolysaccharide Model of Parkinson's Disease. ( Bobrovskaya, L; Deng, I; Garg, S; Zhou, XF, 2022) |
| " Edaravone might be a hopeful therapeutic option for PD, although the high therapeutic dosage remains to be solved for the clinical application." | 1.35 | Neuroprotective effects of edaravone-administration on 6-OHDA-treated dopaminergic neurons. ( Agari, T; Baba, T; Date, I; Jing, M; Kameda, M; Leung, H; Matsui, T; Miyoshi, Y; Morimoto, T; Muraoka, K; Shingo, T; Tajiri, N; Uozumi, T; Wang, F; Yasuhara, T; Yuan, WJ, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deng, I | 1 |
| Garg, S | 1 |
| Zhou, XF | 1 |
| Bobrovskaya, L | 1 |
| Jiao, Y | 1 |
| Zheng, Y | 1 |
| Song, CJ | 1 |
| Kapoor, S | 1 |
| Yuan, WJ | 1 |
| Yasuhara, T | 1 |
| Shingo, T | 1 |
| Muraoka, K | 1 |
| Agari, T | 1 |
| Kameda, M | 1 |
| Uozumi, T | 1 |
| Tajiri, N | 1 |
| Morimoto, T | 1 |
| Jing, M | 1 |
| Baba, T | 1 |
| Wang, F | 1 |
| Leung, H | 1 |
| Matsui, T | 1 |
| Miyoshi, Y | 1 |
| Date, I | 1 |
4 other studies available for edaravone and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
The Effects of Novel Formulations of Edaravone and Curcumin in the Mouse Intrastriatal Lipopolysaccharide Model of Parkinson's Disease.
Topics: alpha-Synuclein; Animals; Anti-Inflammatory Agents; Curcumin; Disease Models, Animal; Edaravone; Lip | 2022 |
[Protective effect of edaravone on balance of mitochondrial fusion and fission in MPP
Topics: 1-Methyl-4-phenylpyridinium; Animals; Dynamins; Edaravone; GTP Phosphohydrolases; Mitochondria; Mito | 2020 |
Edaravone and Its Protective Effects against Disease Progression in Neurological Conditions Besides Strokes.
Topics: Alzheimer Disease; Animals; Antiparkinson Agents; Brain; Disease Models, Animal; Edaravone; Humans; | 2017 |
Neuroprotective effects of edaravone-administration on 6-OHDA-treated dopaminergic neurons.
Topics: Animals; Antipyrine; Cell Survival; Cells, Cultured; Dopamine; Edaravone; Female; Mice; Mice, Inbred | 2008 |